ArticleInfectious agents and cancer2025
China's actions for post-political commitment to global strategy to accelerate cervical cancer elimination.
Article in Infectious agents and cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Observational
- Risk-stratified surveillance after LEEP: a nomogram integrating HPV persistence, margin status, and clinical factors to predict CIN2+ recurrence.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChina is among the largest contributors to the global cervical cancer burden. Problems such as insufficient vaccine supply, high vaccine prices, and insufficient policy support hindering vaccine popularization need to be solved.
methodsIn the present study, we employed a qualitative research methodology to retrieve and organize policy documents on cervical cancer from 31 provincial and central governments by the documentation method.
resultsThe current relevant action program of the Chinese government places strong emphasis on screening and treatment; however, the absence of a consistent national HPV vaccination policy remains the most critical gap in China's strategy to achieve elimination. DISCUSSION: Based on the findings of this study, several key recommendations emerge to advance China's political commitment to the Global Strategy to Accelerate the Elimination of Cervical Cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.